HBV antigen specific dendritic cells (The No.180 Hospital)

HBV抗原特异性树突细胞（第180医院）

Report date: 2025/03/18 20:00:05

Base Information

Drug NameHBV antigen specific dendritic cells (The No.180 Hospital)
Drug Alias NameHPDC-T cellsHepatitis B Vaccine activated-DCs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe No.180 Hospital Of People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Jiao Tong University School of Medicine
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A